Revenue for the period showed marginal growth, rising to 17.24 billion yen from 16.75 billion yen a year earlier. Despite this uptick in top-line performance, profitability collapsed under the weight of rising expenses. Operating profit plummeted to 68 million yen, down from 152 million yen in the previous year, while pretax profit narrowed to 79 million yen from 115 million yen.
In section Market Quotes
Pharmarise Holdings Reports Doubled Net Loss in First Quarter
A net loss of 36 million yen for the first quarter ending August 31 marks a significant downturn for Pharmarise Holdings Corp., effectively doubling the 18 million yen loss recorded during the same period last year. The results, prepared under Japanese accounting standards, reflect deepening financial pressure on the pharmacy operator.
Diluted earnings per share dropped to a loss of 3.20 yen compared to a loss of 1.62 yen in the prior year's first quarter. The widening deficit highlights the company's struggle to translate revenue gains into bottom-line stability as costs continue to outpace its commercial expansion.
Comments (0)
No comments yet. Be the first!